Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 16 AL 30

PUBMED

Proteomic changes in the brains of Huntington's disease mouse models reflect pathology and implicate mitochondrial changes.

Deschepper M, Hoogendoorn B, Brooks S, Dunnett SB, Jones L.

Brain Res Bull. 2012 Jun 1;88(2-3):210-22. doi: 10.1016/j.brainresbull.2011.01.012.

0

0

0

PUBMED

Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease.

Tang B, Becanovic K, Desplats PA, Spencer B, Hill AM, Connolly C, Masliah E, Leavitt BR, Thomas EA.

Hum Mol Genet. 2012 Jul 15;21(14):3097-111. doi: 10.1093/hmg/dds132.

0

0

0

PUBMED

Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.

Martin B, Chadwick W, Cong WN, Pantaleo N, Daimon CM, Golden EJ, Becker KG, Wood WH 3rd, Carlson OD, Egan JM, Maudsley S.

J Biol Chem. 2012 Sep 14;287(38):31766-82. doi: 10.1074/jbc.M112.387316.

0

0

0

PUBMED

Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.

Prime ME, Brookfield FA, Courtney SM, Gaines S, Marston RW, Ichihara O, Li M, Vaidya D, Williams H, Pedret-Dunn A, Reed L, Schaertl S, Toledo-Sherman L, Beconi M, Macdonald D, Muñoz-Sanjuan I, Domingu

ACS Med Chem Lett. 2012 Aug 9;3(9):731-5. doi: 10.1021/ml3001352.

0

0

0

PUBMED

The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease mice.

Reiner A, Lafferty DC, Wang HB, Del Mar N, Deng YP.

Neurobiol Dis. 2012 Jul;47(1):75-91. doi: 10.1016/j.nbd.2012.03.025.

0

0

0

PUBMED

Benign hereditary chorea 2: pathological findings in an autopsy case.

Yoshida Y, Nunomura J, Shimohata T, Nanjo H, Miyata H.

Neuropathology. 2012 Oct;32(5):557-65. doi: 10.1111/j.1440-1789.2011.01288.x.

0

0

0

PUBMED

Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.

Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio W, McConnell K, Connor D, Murphy C, Oakeshott S, Kwan M, Beltran J, Ghavami A, Brunner D, Park LC

PLoS One. 2012;7(12):e49838. doi: 10.1371/journal.pone.0049838.

0

0

0

PUBMED

[Schizophrenia-like psychotic symptoms in a patient with confirmed Huntington's disease: a case report].

Grabski B, Siwek M, Dudek D, Jaeschke R, Banaszkiewicz K.

Psychiatr Pol. 2012 Jul-Aug;46(4):665-75. Polish.

0

0

0

PUBMED

Quantitative proteomic analysis of human substantia nigra in Alzheimer's disease, Huntington's disease and Multiple sclerosis.

Chen S, Lu FF, Seeman P, Liu F.

Neurochem Res. 2012 Dec;37(12):2805-13. doi: 10.1007/s11064-012-0874-2.

0

0

0

PUBMED

Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells.

Jeon I, Lee N, Li JY, Park IH, Park KS, Moon J, Shim SH, Choi C, Chang DJ, Kwon J, Oh SH, Shin DA, Kim HS, Do JT, Lee DR, Kim M, Kang KS, Daley GQ, Brundin P, Song J.

Stem Cells. 2012 Sep;30(9):2054-62. doi: 10.1002/stem.1135. Erratum in: Stem Cells. 2012 Nov;30(11):2602.

0

0

0

PUBMED

Bone marrow transplantation confers modest benefits in mouse models of Huntington's disease.

Kwan W, Magnusson A, Chou A, Adame A, Carson MJ, Kohsaka S, Masliah E, Möller T, Ransohoff R, Tabrizi SJ, Björkqvist M, Muchowski PJ.

J Neurosci. 2012 Jan 4;32(1):133-42. doi: 10.1523/JNEUROSCI.4846-11.2012.

0

0

0

PUBMED

A complementary diffusion tensor imaging (DTI)-histological study in a model of Huntington's disease.

Van Camp N, Blockx I, Camón L, de Vera N, Verhoye M, Veraart J, Van Hecke W, Martínez E, Soria G, Sijbers J, Planas AM, Van der Linden A.

Neurobiol Aging. 2012 May;33(5):945-59. doi: 10.1016/j.neurobiolaging.2010.07.001.

0

0

0

PUBMED

Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease.

Chaturvedi RK, Hennessey T, Johri A, Tiwari SK, Mishra D, Agarwal S, Kim YS, Beal MF.

Hum Mol Genet. 2012 Aug 1;21(15):3474-88. doi: 10.1093/hmg/dds178.

0

0

0

PUBMED

Eugenics, Heredity, and Huntington's Disease: A Brief Historical Perspective.

Wexler A.

J Huntingtons Dis. 2012;1(2):139-41. doi: 10.3233/JHD-129007. No abstract available.

0

0

0

PUBMED

An evidence-based approach in the treatment of Huntington's disease.

Mestre TA, Ferreira JJ.

Parkinsonism Relat Disord. 2012 May;18(4):316-20. doi: 10.1016/j.parkreldis.2011.10.021. Review.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy